2002
DOI: 10.1186/1471-2407-2-14
|View full text |Cite
|
Sign up to set email alerts
|

Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells

Abstract: BackgroundImmunomagnetic enrichment followed by RT-PCR (immunobead RT-PCR) is an efficient methodology to identify disseminated carcinoma cells in the blood and bone marrow. The RT-PCR assays must be both specific for the tumor cells and sufficiently sensitive to enable detection of single tumor cells. We have developed a method to test RT-PCR assays for any cancer. This has been investigated using a panel of RT-PCR markers suitable for the detection of breast cancer cells.MethodsIn the assay, a single cell li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 34 publications
(27 citation statements)
references
References 22 publications
1
25
0
1
Order By: Relevance
“…Moreover, although LNs from patients with benign disease were negative for MUC1, 3 out of 4 PBMNs from healthy volunteers gave positive results demonstrating a crossreaction with noncarcinomatous cells. These results, already reported by others, 24,25 could be due to expression of MUC1 mRNA by skin sebaceous and sweat glands contaminating blood samples collected by transcutaneous venipuncture 34 or by monocytes. 35 Therefore, MUC1 mRNA detection was not considered to be a reliable marker for the detection of micrometastatic cells.…”
Section: Discussionsupporting
confidence: 70%
See 1 more Smart Citation
“…Moreover, although LNs from patients with benign disease were negative for MUC1, 3 out of 4 PBMNs from healthy volunteers gave positive results demonstrating a crossreaction with noncarcinomatous cells. These results, already reported by others, 24,25 could be due to expression of MUC1 mRNA by skin sebaceous and sweat glands contaminating blood samples collected by transcutaneous venipuncture 34 or by monocytes. 35 Therefore, MUC1 mRNA detection was not considered to be a reliable marker for the detection of micrometastatic cells.…”
Section: Discussionsupporting
confidence: 70%
“…21 The 3 markers were mRNAs from cytokeratin 19 (CK19), cytokeratin 7 (CK7) and mucin type 1 (MUC1), as CK19 22,23 and CK7 23 have been demonstrated to be components of the cancer cell cytoskeleton in NSCLC and MUC1 is a cell surface glycoprotein expressed in lung tissue. Although cross-reaction with noncarcinomatous cells has been previously reported, 24,25 MUC1 has been shown to be expressed in most NSCLCs (approximately 80-100%) 16 and is used for the detection of occult cancer cells. The aim of this study was therefore to test the accuracy of each of these markers as well as their combined use.…”
mentioning
confidence: 99%
“…Use of the immunobead technique for the prior isolation of epithelial cells has two advantages over RT-PCR using RNA from whole samples: first, the possibility of detecting free mRNA that may be present in the plasma or attached to blood cells of some cancer patients is avoided (33); second, the possibility of detecting ''illegitimate'' transcription from other cells (34) is substantially reduced. The tumor specificity of the CEA marker has been shown to improve when used in the immunobead RT-PCR method (12,35) compared with the use of RNA from density gradientseparated blood cells in RT-PCR (9). As different molecular markers were expressed at different levels in any individual tumor, a panel of markers that we found to be overexpressed in most tumors was used to minimize the possibility of falsenegative results.…”
Section: Discussionmentioning
confidence: 99%
“…PCR was accomplished following the protocol of Raynor et al (2002). In brief, CCs were collected after hyaluronidase treatment of bovine COCs and a fraction of the cells were lysed and stored at 2 80 8C.…”
Section: Quantitation Of Egfr Mrna and Protein Levels In Ccsmentioning
confidence: 99%